ArticleACS central science2023

New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance.

Akil A Kalathil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.